UMediC Group Berhad (0256) - Cash Flow Conversion Efficiency
Based on the latest financial reports, UMediC Group Berhad (0256) has a cash flow conversion efficiency ratio of -0.034x as of October 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM-2.80 Million ≈ $-702.49K USD) by net assets (RM83.20 Million ≈ $20.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See UMediC Group Berhad (0256) net asset quality to measure how much of total assets are equity-financed.
UMediC Group Berhad - Cash Flow Conversion Efficiency Trend (2020–2025)
This chart illustrates how UMediC Group Berhad's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check UMediC Group Berhad (0256) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
UMediC Group Berhad Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of UMediC Group Berhad ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Stakeholder Gold Corp
V:SRC
|
-0.016x |
|
Mereo BioPharma Group plc
F:MAH0
|
-0.188x |
|
SG Corporation
KO:004060
|
0.006x |
|
Denge Yatirim Holding AS
IS:DENGE
|
-0.187x |
|
Levinski Ofer
TA:LEOF
|
-0.294x |
|
TDb Split Corp
TO:XTD
|
-0.045x |
|
Midland Exploration Inc
V:MD
|
-0.011x |
|
Elcomtec Co. Ltd
KQ:037950
|
0.006x |
Annual Cash Flow Conversion Efficiency for UMediC Group Berhad (2020–2025)
The table below shows the annual cash flow conversion efficiency of UMediC Group Berhad from 2020 to 2025. For the full company profile with market capitalisation and key ratios, see UMediC Group Berhad (0256) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-07-31 | RM81.35 Million ≈ $20.42 Million |
RM11.18 Million ≈ $2.81 Million |
0.137x | +131.41% |
| 2024-07-31 | RM72.77 Million ≈ $18.27 Million |
RM4.32 Million ≈ $1.09 Million |
0.059x | +109.05% |
| 2023-07-31 | RM63.48 Million ≈ $15.94 Million |
RM1.80 Million ≈ $452.94K |
0.028x | -82.34% |
| 2022-07-31 | RM52.68 Million ≈ $13.23 Million |
RM8.48 Million ≈ $2.13 Million |
0.161x | -30.61% |
| 2021-07-31 | RM15.74 Million ≈ $3.95 Million |
RM3.65 Million ≈ $916.46K |
0.232x | +139.33% |
| 2020-07-31 | RM6.63 Million ≈ $1.67 Million |
RM-3.91 Million ≈ $-981.91K |
-0.590x | -- |
About UMediC Group Berhad
UMediC Group Berhad, an investment holding company, develops, manufactures, markets, and distributes medical devices and consumables in Malaysia, the Asia Pacific, the Americas, Europe, the Middle East, Africa, and Oceania. The company operates nursing homes and healthcare centers, and other related services; markets and distributes laboratory equipment and consumables; and provides after-sales s… Read more